Currently predicting for Thu, 4 Jun 2026

COLL Prediction Chart

COLL Predictions History

Latest community submissions for COLL.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 5, 2026 $46.07 +1.19% $45.68 V 99.14% 3
Jan 5, 2026 $45.87 +0.74% $45.68 V 99.59% 5
Jan 5, 2026 $45.53 +0.00% $45.68 X 99.67% 4
Jul 11, 2025 $32.79 -0.65% $32.52 V 99.18% 3
Jul 11, 2025 $32.67 -1.00% $32.52 V 99.54% 5
Jan 17, 2025 $32.96 -1.51% $33.35 V 98.82% 2
Jan 17, 2025 $33.15 -0.94% $33.35 V 99.39% 4
Jan 17, 2025 $27.49 -16.60% $33.35 X 82.43% 1
Nov 4, 2024 $33.98 +1.56% $32.72 X 96.14% 0
Nov 4, 2024 $33.79 +0.98% $32.72 X 96.74% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for COLL with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT COLLEGIUM PHARMACEUTICAL
Collegium Pharmaceutical
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE